These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 27773816)

  • 1. High expression of CREPT promotes tumor growth and is correlated with poor prognosis in colorectal cancer.
    Zheng G; Li W; Zuo B; Guo Z; Xi W; Wei M; Chen P; Wen W; Yang AG
    Biochem Biophys Res Commun; 2016 Nov; 480(3):436-442. PubMed ID: 27773816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CREPT facilitates colorectal cancer growth through inducing Wnt/β-catenin pathway by enhancing p300-mediated β-catenin acetylation.
    Zhang Y; Wang S; Kang W; Liu C; Dong Y; Ren F; Wang Y; Zhang J; Wang G; To KF; Zhang X; Sung JJ; Chang Z; Yu J
    Oncogene; 2018 Jun; 37(26):3485-3500. PubMed ID: 29563608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of CREPT confers colorectal cancer sensitivity to fluorouracil.
    Kuang YS; Wang Y; Ding LD; Yang L; Wang Y; Liu SH; Zhu BT; Wang XN; Liu HY; Li J; Chang ZJ; Wang YY; Jia BQ
    World J Gastroenterol; 2018 Jan; 24(4):475-483. PubMed ID: 29398868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell cycle-related and expression-elevated protein in tumor overexpression is associated with proliferation behaviors and poor prognosis in non-small-cell lung cancer.
    Li W; Zheng G; Xia J; Yang G; Sun J; Wang X; Wen M; Sun Y; Zhang Z; Jin F
    Cancer Sci; 2018 Apr; 109(4):1012-1023. PubMed ID: 29397041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-383 acts as a tumor suppressor in colorectal cancer by modulating CREPT/RPRD1B expression.
    Li J; Smith AR; Marquez RT; Li J; Li K; Lan L; Wu X; Zhao L; Ren F; Wang Y; Wang Y; Jia B; Xu L; Chang Z
    Mol Carcinog; 2018 Oct; 57(10):1408-1420. PubMed ID: 29938829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CREPT serves as a biomarker of poor survival in pancreatic ductal adenocarcinoma.
    Yang G; Wang Y; Xiao J; Zhao F; Qiu J; Liu Y; Chen G; Cao Z; You L; Zheng L; Zhang T; Zhao Y
    Cell Oncol (Dordr); 2021 Apr; 44(2):345-355. PubMed ID: 33125631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knocking-down of CREPT prohibits the progression of oral squamous cell carcinoma and suppresses cyclin D1 and c-Myc expression.
    Ma J; Ren Y; Zhang L; Kong X; Wang T; Shi Y; Bu R
    PLoS One; 2017; 12(4):e0174309. PubMed ID: 28369091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of CREPT restrains gastric cancer growth by regulation of cycle arrest, migration and apoptosis via ROS-regulated p53 pathway.
    Sun M; Si G; Sun HS; Si FC
    Biochem Biophys Res Commun; 2018 Feb; 496(4):1183-1190. PubMed ID: 29402413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SPON2, a newly identified target gene of MACC1, drives colorectal cancer metastasis in mice and is prognostic for colorectal cancer patient survival.
    Schmid F; Wang Q; Huska MR; Andrade-Navarro MA; Lemm M; Fichtner I; Dahlmann M; Kobelt D; Walther W; Smith J; Schlag PM; Stein U
    Oncogene; 2016 Nov; 35(46):5942-5952. PubMed ID: 26686083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. UBR5 Contributes to Colorectal Cancer Progression by Destabilizing the Tumor Suppressor ECRG4.
    Wang J; Zhao X; Jin L; Wu G; Yang Y
    Dig Dis Sci; 2017 Oct; 62(10):2781-2789. PubMed ID: 28856538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upregulation of spondin-2 predicts poor survival of colorectal carcinoma patients.
    Zhang Q; Wang XQ; Wang J; Cui SJ; Lou XM; Yan B; Qiao J; Jiang YH; Zhang LJ; Yang PY; Liu F
    Oncotarget; 2015 Jun; 6(17):15095-110. PubMed ID: 25945835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CREPT/RPRD1B associates with Aurora B to regulate Cyclin B1 expression for accelerating the G2/M transition in gastric cancer.
    Ding L; Yang L; He Y; Zhu B; Ren F; Fan X; Wang Y; Li M; Li J; Kuang Y; Liu S; Zhai W; Ma D; Ju Y; Liu Q; Jia B; Sheng J; Chang Z
    Cell Death Dis; 2018 Dec; 9(12):1172. PubMed ID: 30518842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of SMC1A overexpression as a predictor of poor prognosis in late stage colorectal cancer.
    Wang J; Yu S; Cui L; Wang W; Li J; Wang K; Lao X
    BMC Cancer; 2015 Mar; 15():90. PubMed ID: 25884313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SOX12 promotes colorectal cancer cell proliferation and metastasis by regulating asparagine synthesis.
    Du F; Chen J; Liu H; Cai Y; Cao T; Han W; Yi X; Qian M; Tian D; Nie Y; Wu K; Fan D; Xia L
    Cell Death Dis; 2019 Mar; 10(3):239. PubMed ID: 30858360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CREPT regulated by miR-138 promotes breast cancer progression.
    Liang Z; Feng Q; Xu L; Li S; Zhou L
    Biochem Biophys Res Commun; 2017 Nov; 493(1):263-269. PubMed ID: 28893536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-501-3p restricts prostate cancer growth through regulating cell cycle-related and expression-elevated protein in tumor/cyclin D1 signaling.
    Zhang Z; Shao L; Wang Y; Luo X
    Biochem Biophys Res Commun; 2019 Feb; 509(3):746-752. PubMed ID: 30621914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of ZNF169 promotes the growth and proliferation of colorectal cancer cells via the upregulation of ANKZF1.
    Zhang J; Wang Y; Hou S; Chi X; Ding D; Xue M; Zhang M; Wang J; Shuai J; Sun H; Gao Q; Kang C
    Oncol Rep; 2024 Jun; 51(6):. PubMed ID: 38666541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TRIM47 is up-regulated in colorectal cancer, promoting ubiquitination and degradation of SMAD4.
    Liang Q; Tang C; Tang M; Zhang Q; Gao Y; Ge Z
    J Exp Clin Cancer Res; 2019 Apr; 38(1):159. PubMed ID: 30979374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SLC25A22 Promotes Proliferation and Survival of Colorectal Cancer Cells With KRAS Mutations and Xenograft Tumor Progression in Mice via Intracellular Synthesis of Aspartate.
    Wong CC; Qian Y; Li X; Xu J; Kang W; Tong JH; To KF; Jin Y; Li W; Chen H; Go MY; Wu JL; Cheng KW; Ng SS; Sung JJ; Cai Z; Yu J
    Gastroenterology; 2016 Nov; 151(5):945-960.e6. PubMed ID: 27451147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upregulation of nemo-like kinase is an independent prognostic factor in colorectal cancer.
    Zhang W; He J; Du Y; Gao XH; Liu Y; Liu QZ; Chang WJ; Cao GW; Fu CG
    World J Gastroenterol; 2015 Aug; 21(29):8836-47. PubMed ID: 26269673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.